BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

705 related articles for article (PubMed ID: 30617651)

  • 1. Follow-up of fatty acid β-oxidation disorders in expanded newborn screening era.
    Janeiro P; Jotta R; Ramos R; Florindo C; Ventura FV; Vilarinho L; Tavares de Almeida I; Gaspar A
    Eur J Pediatr; 2019 Mar; 178(3):387-394. PubMed ID: 30617651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic characteristics and follow-up of patients with fatty acid β-oxidation disorders through expanded newborn screening in a Northern Chinese population.
    Wang S; Leng J; Diao C; Wang Y; Zheng R
    J Pediatr Endocrinol Metab; 2020 May; 33(6):683-690. PubMed ID: 32447334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcome of expanded newborn screening at Boston children's hospital: benefits and challenges in defining true disease.
    Landau YE; Waisbren SE; Chan LM; Levy HL
    J Inherit Metab Dis; 2017 Mar; 40(2):209-218. PubMed ID: 28054209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Newborn Screening and Early Dietary Management on Clinical Outcome of Patients with Long Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency and Medium Chain Acyl-CoA Dehydrogenase Deficiency-A Retrospective Nationwide Study.
    Rücklová K; Hrubá E; Pavlíková M; Hanák P; Farolfi M; Chrastina P; Vlášková H; Kousal B; Smolka V; Foltenová H; Adam T; Friedecký D; Ješina P; Zeman J; Kožich V; Honzík T
    Nutrients; 2021 Aug; 13(9):. PubMed ID: 34578803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Newborn screening for medium-chain acyl-CoA dehydrogenase deficiency: regional experience and high incidence of carnitine deficiency.
    Couce ML; Sánchez-Pintos P; Diogo L; Leão-Teles E; Martins E; Santos H; Bueno MA; Delgado-Pecellín C; Castiñeiras DE; Cocho JA; García-Villoria J; Ribes A; Fraga JM; Rocha H
    Orphanet J Rare Dis; 2013 Jul; 8():102. PubMed ID: 23842438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of newborn screening for very-long-chain acyl-CoA dehydrogenase deficiency on genetic, enzymatic, and clinical outcomes.
    Bleeker JC; Kok IL; Ferdinandusse S; van der Pol WL; Cuppen I; Bosch AM; Langeveld M; Derks TGJ; Williams M; de Vries M; Mulder MF; Gozalbo ER; de Sain-van der Velden MGM; Rennings AJ; Schielen PJCI; Dekkers E; Houtkooper RH; Waterham HR; Pras-Raves ML; Wanders RJA; van Hasselt PM; Schoenmakers M; Wijburg FA; Visser G
    J Inherit Metab Dis; 2019 May; 42(3):414-423. PubMed ID: 30761551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tandem mass spectrometry analysis and genetic diagnosis of neonates with fatty acid oxidation disorders in central and northern regions of Guangxi].
    Tan J; Chen D; Huang J; Chang R; Yan T; Cai R
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Nov; 36(11):1067-1072. PubMed ID: 31703127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proposal for an individualized dietary strategy in patients with very long-chain acyl-CoA dehydrogenase deficiency.
    Bleeker JC; Kok IL; Ferdinandusse S; de Vries M; Derks TGJ; Mulder MF; Williams M; Gozalbo ER; Bosch AM; van den Hurk DT; de Sain-van der Velden MGM; Waterham HR; Wijburg FA; Visser G
    J Inherit Metab Dis; 2019 Jan; 42(1):159-168. PubMed ID: 30740737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management and diagnosis of mitochondrial fatty acid oxidation disorders: focus on very-long-chain acyl-CoA dehydrogenase deficiency.
    Yamada K; Taketani T
    J Hum Genet; 2019 Feb; 64(2):73-85. PubMed ID: 30401918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and biological features at diagnosis in mitochondrial fatty acid beta-oxidation defects: a French pediatric study of 187 patients.
    Baruteau J; Sachs P; Broué P; Brivet M; Abdoul H; Vianey-Saban C; Ogier de Baulny H
    J Inherit Metab Dis; 2013 Sep; 36(5):795-803. PubMed ID: 23053472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatty liver in a two days old neonate.
    Arivalagan P; Husain MS; Subramaniam K; Kaslan MRM
    Med J Malaysia; 2019 Oct; 74(5):454-455. PubMed ID: 31649231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Screening for fatty acid oxidation disorders of newborns in Zhejiang province:prevalence, outcome and follow-up].
    Zheng J; Zhang Y; Hong F; Yang J; Tong F; Mao H; Huang X; Zhou X; Yang R; Zhao Z; Huang X
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2017 May; 46(3):248-255. PubMed ID: 29039165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expanded newborn screening in New South Wales: missed cases.
    Estrella J; Wilcken B; Carpenter K; Bhattacharya K; Tchan M; Wiley V
    J Inherit Metab Dis; 2014 Nov; 37(6):881-7. PubMed ID: 24970580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective biochemical screening of fatty acid oxidation disorders in postmortem livers of 418 cases of sudden death in the first year of life.
    Boles RG; Buck EA; Blitzer MG; Platt MS; Cowan TM; Martin SK; Yoon H; Madsen JA; Reyes-Mugica M; Rinaldo P
    J Pediatr; 1998 Jun; 132(6):924-33. PubMed ID: 9627580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and biochemical outcome of patients with very long-chain acyl-CoA dehydrogenase deficiency.
    Rovelli V; Manzoni F; Viau K; Pasquali M; Longo N
    Mol Genet Metab; 2019 May; 127(1):64-73. PubMed ID: 31031081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infants suspected to have very-long chain acyl-CoA dehydrogenase deficiency from newborn screening.
    Merritt JL; Vedal S; Abdenur JE; Au SM; Barshop BA; Feuchtbaum L; Harding CO; Hermerath C; Lorey F; Sesser DE; Thompson JD; Yu A
    Mol Genet Metab; 2014 Apr; 111(4):484-92. PubMed ID: 24503138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Very long-chain acyl-coenzyme A dehydrogenase deficiency in Chinese patients: eight case reports, including one case of prenatal diagnosis.
    Li X; Ding Y; Ma Y; Liu Y; Wang Q; Song J; Yang Y
    Eur J Med Genet; 2015 Mar; 58(3):134-9. PubMed ID: 25652019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatty acid oxidation flux predicts the clinical severity of VLCAD deficiency.
    Diekman EF; Ferdinandusse S; van der Pol L; Waterham HR; Ruiter JP; Ijlst L; Wanders RJ; Houten SM; Wijburg FA; Blank AC; Asselbergs FW; Houtkooper RH; Visser G
    Genet Med; 2015 Dec; 17(12):989-94. PubMed ID: 25834949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The first three years of screening for medium chain acyl-CoA dehydrogenase deficiency (MCADD) by newborn screening ontario.
    Kennedy S; Potter BK; Wilson K; Fisher L; Geraghty M; Milburn J; Chakraborty P
    BMC Pediatr; 2010 Nov; 10():82. PubMed ID: 21083904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective screening for inborn errors of metabolism on clinical patients using tandem mass spectrometry in China: a four-year report.
    Han LS; Ye J; Qiu WJ; Gao XL; Wang Y; Gu XF
    J Inherit Metab Dis; 2007 Aug; 30(4):507-14. PubMed ID: 17347912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.